All questions
Question 1
A researcher observes that when epinephrine binds to its receptor on liver cells, the intracellular concentration of cyclic AMP increases within seconds, but the receptor itself does not undergo autophosphorylation. However, when insulin binds to its receptor on the same cells, autophosphorylation occurs but no change in cyclic AMP is detected. What can be concluded about these two receptors?
- Both receptors are G-protein coupled receptors that activate different downstream effectors in the cell
- The epinephrine receptor is a G-protein coupled receptor while the insulin receptor is a receptor tyrosine kinase (correct answer)
- Both receptors are receptor tyrosine kinases but they phosphorylate different substrate proteins upon activation
- The epinephrine receptor is a ligand-gated ion channel while the insulin receptor is a nuclear hormone receptor
- The epinephrine receptor is a receptor tyrosine kinase while the insulin receptor is a G-protein coupled receptor
Explanation: When you encounter questions about receptor signaling, focus on the key distinguishing features of each receptor type: what happens when they're activated and what downstream pathways they trigger.
The epinephrine receptor shows classic G-protein coupled receptor (GPCR) behavior. GPCRs don't phosphorylate themselves - instead, they undergo conformational changes that activate G-proteins, which then stimulate enzymes like adenylyl cyclase to produce cyclic AMP. The rapid cAMP increase you observe is the hallmark of this pathway.
The insulin receptor demonstrates typical receptor tyrosine kinase (RTK) behavior. RTKs have intrinsic kinase activity and undergo autophosphorylation when activated - they literally phosphorylate themselves on tyrosine residues. RTKs don't use the cAMP pathway, which explains why no cAMP change occurs with insulin binding.
This reasoning confirms answer B is correct.
Answer A is wrong because insulin doesn't use a GPCR - the autophosphorylation rules this out completely. Answer C incorrectly classifies the epinephrine receptor as an RTK, but epinephrine receptors cannot autophosphorylate since they lack kinase domains. Answer D misidentifies both receptors entirely - ligand-gated ion channels control ion flow across membranes (not relevant here), and nuclear hormone receptors are intracellular transcription factors, not membrane-bound receptors that respond to epinephrine or insulin.
Remember this pattern: autophosphorylation always indicates an RTK, while rapid cAMP changes signal GPCR activation. These are mutually exclusive pathways that help you distinguish receptor types quickly.
Question 2
A mutation in a cell surface receptor prevents it from changing conformation when its ligand binds, but the ligand binding affinity remains normal. If this receptor normally activates gene transcription within 30 minutes of ligand binding, which type of receptor is most likely affected?
- A ligand-gated sodium channel that directly depolarizes the membrane to activate transcription factors
- A G-protein coupled receptor that activates a signaling cascade leading to transcriptional activation
- A receptor tyrosine kinase that autophosphorylates and recruits transcriptional regulatory proteins
- A nuclear hormone receptor that directly binds DNA and regulates gene expression (correct answer)
- An integrin receptor that undergoes conformational changes to activate intracellular kinase cascades
Explanation: When you encounter questions about receptor function and gene transcription, focus on how different receptor types translate ligand binding into cellular responses. The key clue here is that the receptor can still bind its ligand normally but cannot change conformation, yet it's supposed to activate transcription within 30 minutes.
Nuclear hormone receptors (answer D) are unique because they function as ligand-activated transcription factors. When the ligand binds, it causes a conformational change that allows the receptor to bind DNA and directly regulate gene expression. If this conformational change is blocked by mutation, the receptor becomes a "dead" transcription factor - it can bind hormone but cannot activate genes. The 30-minute timeframe fits perfectly with direct transcriptional activation.
Answer A is incorrect because ligand-gated channels work through rapid ion flux and membrane depolarization - this wouldn't require conformational changes for transcriptional effects, and the timeline would be much faster (seconds to minutes).
Answer B fails because G-protein coupled receptors absolutely require conformational changes to activate their associated G-proteins. Without this shape change, no signaling cascade could occur.
Answer C is wrong because receptor tyrosine kinases depend entirely on ligand-induced conformational changes for autophosphorylation. No conformational change means no kinase activation, no phosphorylation, and no downstream signaling.
Remember: Nuclear receptors are transcription factors first, receptors second. When you see transcriptional effects combined with normal ligand binding but defective signaling, think about whether the receptor itself might be the transcriptional machinery that's been broken.
Question 3
During a patch-clamp experiment, application of acetylcholine to a muscle cell causes an immediate inward current that persists only as long as acetylcholine is present. When acetylcholine is removed, the current stops within milliseconds. However, application of the same concentration of cortisol to the same cell produces no detectable current change. What explains this difference?
- Acetylcholine binds to a G-protein coupled receptor while cortisol binds to a receptor tyrosine kinase
- Acetylcholine activates a ligand-gated ion channel while cortisol binds to an intracellular nuclear receptor (correct answer)
- Both ligands bind to the same type of receptor but activate different downstream signaling pathways
- Acetylcholine binds to a receptor tyrosine kinase while cortisol activates a G-protein coupled receptor
- Acetylcholine activates a nuclear hormone receptor while cortisol binds to a ligand-gated ion channel
Explanation: When you encounter patch-clamp experiments, focus on the time scale and nature of the response to identify the receptor type involved. Patch-clamp recordings measure electrical currents across cell membranes, so only processes that directly affect ion flow will produce detectable signals.
Acetylcholine's immediate inward current that appears and disappears within milliseconds indicates direct activation of a ligand-gated ion channel. When acetylcholine binds to nicotinic receptors on muscle cells, it causes conformational changes that immediately open sodium channels, creating the rapid current you observe. The current stops quickly when acetylcholine is removed because the channel closes as soon as the ligand dissociates.
Cortisol produces no detectable current because it's a steroid hormone that binds to intracellular nuclear receptors. These receptors function as transcription factors, ultimately changing gene expression—a process that takes hours, not milliseconds, and doesn't directly alter ion channel activity that patch-clamp can detect.
Option A is incorrect because cortisol doesn't bind to receptor tyrosine kinases—those are for protein hormones like insulin. Option C is wrong because acetylcholine and cortisol bind completely different receptor types with vastly different mechanisms. Option D incorrectly assigns acetylcholine to receptor tyrosine kinases and cortisol to GPCRs, neither of which matches their actual mechanisms.
Remember: rapid electrical responses (milliseconds) indicate ligand-gated channels, while steroid hormones work through nuclear receptors and gene transcription, producing slower responses that patch-clamp experiments typically can't detect directly.
Question 4
Researchers studying a novel growth factor find that it causes rapid tyrosine phosphorylation of multiple intracellular proteins within 2 minutes of application. However, when they pre-treat cells with an inhibitor that blocks all kinase activity except receptor tyrosine kinases, the phosphorylation still occurs. What type of receptor most likely mediates this growth factor's effects?
- A G-protein coupled receptor that activates protein kinase A through cyclic AMP elevation
- A ligand-gated calcium channel that activates calcium-dependent protein kinases
- A receptor tyrosine kinase that undergoes autophosphorylation and phosphorylates downstream substrates (correct answer)
- A nuclear hormone receptor that directly phosphorylates target proteins in the nucleus
- A cytokine receptor that associates with and activates JAK family tyrosine kinases
Explanation: When you encounter questions about rapid protein phosphorylation and receptor signaling, focus on matching the timeline, phosphorylation pattern, and inhibitor effects to the appropriate receptor mechanism.
The key clue here is that tyrosine phosphorylation occurs rapidly (within 2 minutes) and persists even when all kinases except receptor tyrosine kinases (RTKs) are blocked. This directly points to RTKs as the mediators. RTKs work by ligand binding causing receptor dimerization, followed by autophosphorylation of tyrosine residues in their cytoplasmic domains. These phosphorylated tyrosines then serve as docking sites for signaling proteins, which the RTK can directly phosphorylate on tyrosine residues. Since RTK activity isn't blocked by the inhibitor, both the receptor autophosphorylation and downstream substrate phosphorylation continue normally.
Option A is wrong because PKA phosphorylates serine/threonine residues, not tyrosines, and would be blocked by the broad kinase inhibitor. Option B is incorrect because calcium-dependent kinases also primarily target serine/threonine residues and would be inhibited. Additionally, the question doesn't mention calcium involvement. Option D is flawed because nuclear hormone receptors are transcription factors that regulate gene expression over hours, not phosphorylating enzymes that work in minutes.
Remember this pattern: when you see rapid tyrosine phosphorylation that's resistant to broad kinase inhibition but sensitive to RTK-specific blocks, think receptor tyrosine kinases. The timing (minutes) and substrate specificity (tyrosine) are your strongest diagnostic clues.
Question 5
An experiment shows that a particular receptor requires both ligand binding and receptor dimerization to become active. Additionally, active receptors phosphorylate themselves on tyrosine residues and subsequently phosphorylate several downstream signaling proteins. Based on these characteristics, which other property would you expect this receptor to have?
- The ability to directly gate ion channels in the plasma membrane upon activation
- Seven transmembrane domains that couple to heterotrimeric G-proteins
- An intracellular kinase domain that becomes activated following dimerization (correct answer)
- The capacity to directly bind DNA and function as a transcription factor
- Multiple extracellular binding sites for different types of neurotransmitter molecules
Explanation: When you encounter a receptor that requires ligand binding and dimerization for activation, then phosphorylates itself and other proteins on tyrosine residues, you're looking at the classic hallmarks of receptor tyrosine kinases (RTKs). These receptors follow a predictable activation mechanism that you should recognize.
The key insight is understanding the activation sequence: ligand binding causes two receptor molecules to come together (dimerization), which brings their intracellular domains close enough to phosphorylate each other. This autophosphorylation then creates binding sites for downstream signaling proteins, which the receptor can also phosphorylate. For this mechanism to work, the receptor must have an intracellular kinase domain that becomes active upon dimerization, making C correct.
Let's examine why the other options don't fit this pattern. Option A describes ligand-gated ion channels, which open pores for ion flow but don't involve protein phosphorylation. Option B describes G-protein coupled receptors (GPCRs), which have seven membrane-spanning regions and activate heterotrimeric G-proteins rather than functioning as kinases themselves. Option D describes nuclear hormone receptors that directly regulate gene transcription, not membrane receptors that phosphorylate cytoplasmic proteins.
Study tip: When you see tyrosine phosphorylation combined with receptor dimerization, immediately think "receptor tyrosine kinase." RTKs are crucial signaling molecules (like growth factor receptors) and follow this consistent pattern: dimerization → kinase domain activation → autophosphorylation → downstream substrate phosphorylation. Memorizing this sequence will help you quickly identify RTK-related questions.
Question 6
A researcher develops a fluorescent biosensor that detects conformational changes in G-protein α-subunits. When cells expressing this sensor are treated with various signaling molecules, the sensor shows rapid activation with epinephrine and histamine, but no response to insulin or testosterone. What can be concluded about the receptors for these molecules?
- Epinephrine and histamine receptors are ligand-gated ion channels, while insulin and testosterone receptors are nuclear receptors
- All four molecules bind to G-protein coupled receptors, but insulin and testosterone activate different G-protein subtypes
- Epinephrine and histamine bind to G-protein coupled receptors, while insulin and testosterone use other receptor types (correct answer)
- Insulin and testosterone receptors are G-protein coupled receptors, while epinephrine and histamine receptors are receptor tyrosine kinases
- All four receptors are the same type but differ in their downstream signaling kinetics and protein targets
Explanation: When you encounter questions about signaling molecules and their receptors, focus on matching the signal type with the appropriate receptor mechanism. The key insight here is that a fluorescent biosensor specifically designed to detect G-protein α-subunit conformational changes will only respond when G-protein coupled receptors (GPCRs) are activated.
The experimental results tell a clear story: epinephrine and histamine triggered the biosensor, indicating they bind to GPCRs that activate G-proteins. When these receptors are stimulated, the G-protein α-subunit undergoes conformational changes as it exchanges GDP for GTP and dissociates from the βγ subunits - exactly what the biosensor detects. In contrast, insulin and testosterone showed no response, meaning they don't activate GPCRs.
Choice C correctly identifies this pattern: epinephrine and histamine use GPCRs, while insulin and testosterone use different receptor types (insulin binds to receptor tyrosine kinases, testosterone to nuclear receptors).
Choice A incorrectly categorizes epinephrine and histamine receptors as ligand-gated ion channels - these don't involve G-proteins at all. Choice B assumes all four molecules work through GPCRs, which contradicts the experimental data showing no G-protein activation with insulin and testosterone. Choice D completely reverses the experimental findings, claiming the molecules that activated the G-protein sensor (epinephrine and histamine) don't use GPCRs.
Remember: when analyzing receptor mechanisms, let the experimental evidence guide you. If a G-protein biosensor responds, you're dealing with GPCRs. If it doesn't respond, look for alternative receptor pathways like RTKs or nuclear receptors.
Question 7
In a voltage-clamp experiment, a neurotransmitter is applied to a neuron and causes an immediate inward current. The current amplitude is directly proportional to the neurotransmitter concentration, and the current reverses at 0 mV. When the neurotransmitter is washed away, the current immediately disappears. These properties are most consistent with which type of receptor?
- A G-protein coupled receptor that activates adenylyl cyclase and opens cyclic nucleotide-gated channels
- A receptor tyrosine kinase that phosphorylates and activates voltage-gated sodium channels
- A ligand-gated cation channel that directly allows sodium and potassium flux across the membrane (correct answer)
- A nuclear hormone receptor that rapidly modulates the expression of ion channel genes
- A metabotropic receptor that activates protein kinase C to phosphorylate membrane channels
Explanation: When analyzing voltage-clamp experiments, focus on the timing and characteristics of the current response to determine the receptor mechanism involved. The key clues here are the immediate onset, direct concentration dependence, and instant cessation when the ligand is removed.
The correct answer is C because ligand-gated cation channels produce exactly these characteristics. When neurotransmitter binds directly to the channel, it immediately opens, allowing sodium and potassium to flow according to their electrochemical gradients. Since sodium influx dominates at negative potentials, you see an inward current that reverses at 0 mV (where sodium and potassium driving forces balance). The direct binding mechanism explains why current amplitude is proportional to neurotransmitter concentration and why the response disappears instantly upon washout.
Option A is wrong because G-protein coupled receptors involve multiple enzymatic steps (G-protein activation, cAMP production, channel phosphorylation) that take seconds to minutes, not the immediate response described. Option B is incorrect because receptor tyrosine kinases also require time-consuming phosphorylation cascades and wouldn't show instant kinetics. Additionally, voltage-gated sodium channels wouldn't directly explain the concentration dependence or 0 mV reversal potential. Option D is wrong because nuclear hormone receptors work through gene transcription changes that take hours, not immediate current responses.
Remember: immediate, reversible responses to neurotransmitters almost always indicate ligand-gated ion channels, while delayed responses suggest second messenger pathways. The timing of the response is often your biggest clue to the underlying mechanism.
Question 8
A student measures the time course of cellular responses to different signaling molecules. PDGF (platelet-derived growth factor) causes detectable protein phosphorylation within 30 seconds, cortisol shows no effects for 20 minutes but then increases specific protein synthesis, and acetylcholine (at the neuromuscular junction) causes immediate membrane depolarization that lasts only as long as the stimulus. Which receptor types likely mediate these responses, respectively?
- Nuclear receptor, G-protein coupled receptor, ligand-gated ion channel
- G-protein coupled receptor, nuclear receptor, receptor tyrosine kinase
- Receptor tyrosine kinase, nuclear receptor, ligand-gated ion channel (correct answer)
- Ligand-gated ion channel, receptor tyrosine kinase, nuclear receptor
- Receptor tyrosine kinase, G-protein coupled receptor, nuclear receptor
Explanation: When analyzing cellular signaling responses, the key is matching the timing and mechanism to the appropriate receptor type. Each major receptor class has distinct characteristics that determine how quickly and how long cellular responses occur.
PDGF causing protein phosphorylation within 30 seconds indicates a receptor tyrosine kinase (RTK). These receptors have intrinsic kinase activity that directly phosphorylates proteins upon ligand binding, creating rapid enzymatic cascades. The 30-second timeframe is typical for RTK-mediated responses.
Cortisol's 20-minute delay before affecting protein synthesis is characteristic of nuclear receptors. These receptors must translocate to the nucleus, bind DNA, and initiate transcription—a process requiring time for mRNA synthesis, processing, and translation into new proteins. The delay is the hallmark of genomic signaling.
Acetylcholine at the neuromuscular junction causing immediate, stimulus-dependent membrane depolarization describes ligand-gated ion channels. These receptors directly open upon ligand binding, allowing immediate ion flow and membrane potential changes that cease when the ligand dissociates.
Answer A incorrectly places nuclear receptors first (PDGF needs rapid response, not delayed genomic effects). Answer B wrongly assigns GPCR to PDGF (GPCRs typically work through second messengers, not direct phosphorylation) and RTK to cortisol (RTKs don't cause 20-minute delays). Answer D completely reverses the order, mismatching all timing patterns.
Remember: Match timing to mechanism—seconds for ion channels and RTKs, minutes to hours for nuclear receptors requiring gene transcription.
Question 9
A researcher finds that a novel signaling protein can activate two different cell types through distinct mechanisms. In hepatocytes, it causes rapid increases in cyclic AMP and protein kinase A activity. In neurons, it causes immediate sodium influx and membrane depolarization. What types of receptors likely mediate these effects?
- Both cell types use G-protein coupled receptors but with different downstream effector systems
- Hepatocytes use receptor tyrosine kinases while neurons use G-protein coupled receptors
- Hepatocytes use G-protein coupled receptors while neurons use ligand-gated ion channels (correct answer)
- Both cell types use the same receptor tyrosine kinase but couple to different signaling pathways
- Hepatocytes use nuclear hormone receptors while neurons use receptor tyrosine kinases
Explanation: When you encounter questions about signaling proteins causing different cellular responses, focus on matching the specific cellular effects to the appropriate receptor types and their characteristic signaling mechanisms.
The key is analyzing what happens in each cell type. In hepatocytes, you see increased cyclic AMP and protein kinase A activity - this is the classic Gs-protein coupled receptor pathway where adenylyl cyclase generates cAMP as a second messenger. In neurons, immediate sodium influx and depolarization indicates direct ion channel opening, which is characteristic of ligand-gated ion channels that allow rapid ion flow across membranes.
Answer C correctly identifies this distinction: hepatocytes use G-protein coupled receptors (leading to the cAMP cascade) while neurons use ligand-gated ion channels (causing immediate ion influx).
Answer A is wrong because while hepatocytes do use GPCRs, neurons aren't using GPCRs here - the immediate ion influx without second messengers indicates direct channel opening. Answer B incorrectly suggests hepatocytes use receptor tyrosine kinases, but RTKs typically activate different pathways like PI3K/Akt or MAPK, not the cAMP system. Answer D is incorrect because receptor tyrosine kinases don't mediate either response described - neither the cAMP pathway nor direct ion channel function.
Remember that rapid ion movements (milliseconds) suggest ligand-gated channels, while second messenger cascades like cAMP (seconds to minutes) indicate G-protein coupled receptors. Match the timeline and mechanism of cellular responses to identify receptor types.
Question 10
A cell line is genetically modified to lack all heterotrimeric G-proteins. Which of the following signaling responses would you expect to be completely abolished in these cells?
- Insulin-stimulated glucose uptake via receptor tyrosine kinase activation
- Testosterone-induced gene expression through nuclear hormone receptor binding
- Glutamate-induced depolarization through AMPA receptor channel opening
- Dopamine-induced changes in cyclic AMP levels through D1 receptor activation (correct answer)
- EGF-stimulated cell division through epidermal growth factor receptor autophosphorylation
Explanation: When you encounter questions about G-protein signaling, focus on identifying which pathways absolutely require heterotrimeric G-proteins to function. These G-proteins are essential components that couple G-protein coupled receptors (GPCRs) to their downstream effectors.
The dopamine D1 receptor in option D is a classic GPCR that must have heterotrimeric G-proteins to function. When dopamine binds to D1 receptors, it activates Gs proteins, which then stimulate adenylyl cyclase to produce cyclic AMP. Without any heterotrimeric G-proteins, this entire signaling cascade would be completely blocked, making D the correct answer.
Let's examine why the other pathways would remain functional: Option A describes insulin signaling through receptor tyrosine kinases (RTKs), which work through direct protein phosphorylation cascades and don't require G-proteins at all. Option B involves testosterone binding directly to nuclear hormone receptors that act as transcription factors—this is entirely G-protein independent. Option C describes glutamate acting on AMPA receptors, which are ligand-gated ion channels that open directly when glutamate binds, requiring no G-protein intermediates.
The key distinction is that GPCRs like the D1 receptor are completely dependent on heterotrimeric G-proteins for signal transduction, while RTKs, nuclear hormone receptors, and ligand-gated ion channels use entirely different mechanisms that bypass G-proteins altogether.
Study tip: Memorize the major receptor types and their signaling mechanisms. GPCRs always need G-proteins, while RTKs, nuclear receptors, and ion channels use direct mechanisms that don't require them.
Question 11
During embryonic development, a signaling molecule must diffuse through multiple cell layers to reach its target tissue. The molecule is hydrophobic and easily crosses cell membranes. When it reaches target cells, it takes 2-3 hours to produce detectable biological effects, which involve changes in gene expression. Based on these properties, what type of receptor most likely mediates this developmental signal?
- A receptor tyrosine kinase that slowly autophosphorylates and activates transcriptional cascades
- A G-protein coupled receptor that gradually accumulates cyclic nucleotides to threshold levels
- A nuclear hormone receptor that directly regulates transcription after ligand binding (correct answer)
- A ligand-gated ion channel that indirectly affects gene expression through calcium signaling
- A cytokine receptor that associates with JAK kinases to activate STAT transcription factors
Explanation: When analyzing developmental signaling questions, focus on matching the molecule's physical properties with the receptor type and timeframe of effects. The key clues here are that the molecule is hydrophobic, crosses membranes easily, and produces slow effects (2-3 hours) involving gene expression changes.
Nuclear hormone receptors (option C) perfectly match these characteristics. Hydrophobic signaling molecules like steroid hormones, thyroid hormones, and retinoic acid can diffuse directly through cell membranes and cytoplasm to reach nuclear receptors. Once bound, these receptors act as transcription factors, directly binding to DNA and regulating gene expression. This direct transcriptional mechanism naturally requires 2-3 hours because it involves transcription, mRNA processing, translation, and protein accumulation—explaining the delayed but sustained effects typical of developmental signals.
Option A is incorrect because receptor tyrosine kinases are membrane-bound receptors for hydrophilic growth factors that cannot freely cross membranes. Option B fails because G-protein coupled receptors also require hydrophilic ligands and typically produce much faster responses (seconds to minutes) through second messenger systems. Option D is wrong because ligand-gated ion channels respond to hydrophilic neurotransmitters and generate rapid responses (milliseconds), not the slow gene expression changes described.
For cell biology exams, remember this pattern: hydrophobic signaling molecules that produce slow, sustained effects through gene expression changes almost always work through nuclear receptors. The 2-3 hour timeframe is your strongest clue—it's the signature timing of transcriptional responses.
Question 12
A researcher creates a fusion protein consisting of the extracellular domain of an insulin receptor attached to the intracellular domain of a β-adrenergic receptor. When insulin is applied to cells expressing this fusion protein, which response would you predict?
- Rapid tyrosine autophosphorylation followed by activation of MAP kinase pathways
- Immediate sodium influx and membrane depolarization similar to acetylcholine receptors
- Increased intracellular cyclic AMP levels through G-protein activation of adenylyl cyclase (correct answer)
- Direct binding to DNA and activation of insulin-responsive gene transcription
- No response because the fusion protein cannot properly dimerize upon insulin binding
Explanation: When you encounter fusion protein questions, focus on which domain determines the cellular response—the intracellular domain is what matters for signal transduction.
This fusion protein combines insulin's extracellular binding domain with the β-adrenergic receptor's intracellular signaling domain. While insulin will bind to the extracellular portion, the cellular response depends entirely on what happens inside the cell. The β-adrenergic receptor's intracellular domain is coupled to G-proteins that activate adenylyl cyclase, leading to increased cyclic AMP (cAMP) production. Therefore, insulin binding will trigger the β-adrenergic pathway, making C correct.
Let's examine why the other options fail: A describes the normal insulin receptor pathway involving tyrosine kinase activity and MAP kinase activation, but this fusion protein lacks the insulin receptor's intracellular tyrosine kinase domain. B suggests ion channel activity like acetylcholine receptors, but β-adrenergic receptors are G-protein coupled receptors, not ion channels, so no direct sodium influx occurs. D proposes direct DNA binding, but neither insulin receptors nor β-adrenergic receptors function as transcription factors that directly bind DNA—they work through intracellular signaling cascades.
The key insight is that receptor function follows a modular design: extracellular domains determine ligand specificity, while intracellular domains determine the signaling pathway activated. In fusion proteins, you get the binding specificity of one receptor with the signaling mechanism of another. Always focus on the intracellular domain to predict the cellular response.
Question 13
An experimental compound blocks the formation of receptor dimers at the cell surface. Treatment with this compound would most severely impair signaling by which type of receptor?
- G-protein coupled receptors that normally function as monomeric units
- Nuclear hormone receptors that form homodimers on DNA response elements
- Ligand-gated ion channels that require multiple subunits for channel formation
- Receptor tyrosine kinases that require dimerization for autophosphorylation and activation (correct answer)
- Integrin receptors that cluster together to form focal adhesion complexes
Explanation: When you encounter questions about blocking receptor dimerization, focus on which receptor types absolutely require dimer formation to function versus those that can work as single units.
Receptor tyrosine kinases (RTKs) have a unique activation mechanism that makes dimerization essential. When a ligand binds to an RTK, it causes two receptor molecules to come together and form a dimer. This dimerization brings the intracellular kinase domains close enough to phosphorylate each other in a process called autophosphorylation. These phosphorylated tyrosines then serve as docking sites for downstream signaling proteins. Without dimerization, RTKs cannot undergo autophosphorylation and essentially cannot signal at all.
Choice A is incorrect because G-protein coupled receptors that function as monomers would be unaffected by a compound blocking dimerization - they don't need to dimerize to activate their associated G-proteins. Choice B represents a misunderstanding of where nuclear hormone receptors function; while they do form dimers, this occurs in the nucleus on DNA, not at the cell surface where the experimental compound acts. Choice C describes ligand-gated ion channels, but these are typically composed of multiple subunits that assemble during protein synthesis and trafficking, not through dimerization events at the cell surface during signaling.
Remember this key distinction: RTKs are unique among cell surface receptors because their signaling absolutely depends on ligand-induced dimerization. This makes them particularly vulnerable to any treatment that prevents dimer formation, while other receptor types have alternative activation mechanisms.
Question 14
A cell biologist observes that when she treats cells with a particular hormone, there's no detectable response in standard cell culture medium. However, when she adds the hormone to permeabilized cells (with compromised plasma membranes), a robust response occurs within minutes. This hormone most likely binds to which type of receptor?
- A G-protein coupled receptor that requires intact membrane lipid rafts for proper function
- A receptor tyrosine kinase that needs membrane integrity for proper dimerization
- A nuclear hormone receptor that is normally sequestered inside the cell (correct answer)
- A ligand-gated ion channel that requires membrane potential for activation
- An integrin receptor that needs mechanical tension across the membrane for signaling
Explanation: When you encounter a question about hormone responses that differ between intact and permeabilized cells, you're dealing with receptor location and accessibility. The key insight here is that permeabilization allows molecules to enter the cell that normally cannot cross the plasma membrane.
The correct answer is C because nuclear hormone receptors are located inside the cell (either in the cytoplasm or nucleus) rather than on the cell surface. In intact cells, many hormones like steroid hormones (cortisol, testosterone, estrogen) cannot easily cross the lipid bilayer to reach these intracellular receptors. However, when cells are permeabilized, the hormone can freely enter and bind to its nuclear receptor, triggering the response. This explains why no response occurs in normal culture medium but a robust response happens in permeabilized cells.
Answer A is incorrect because G-protein coupled receptors are located on the cell surface where hormones can readily access them in intact cells. Answer B is wrong for the same reason - receptor tyrosine kinases are membrane-bound surface receptors that would function normally in intact cells. Answer D is also incorrect because ligand-gated ion channels are surface receptors, and while they do require membrane potential, the hormone would still be able to reach them in standard culture conditions.
Remember this pattern: when a hormone only works after permeabilization, think intracellular receptors. This distinguishes lipophilic hormones (steroids, thyroid hormones) that cross membranes from hydrophilic hormones that bind surface receptors.
Question 15
A graduate student discovers that a novel neurotransmitter can produce two distinct responses in the same neuron: an immediate electrical response lasting milliseconds and a slower metabolic response developing over minutes. Both responses are blocked when the neurotransmitter binding site is occupied by a competitive antagonist. What is the most likely explanation?
- The neurotransmitter binds to a single receptor type that activates both fast and slow signaling pathways
- The neurotransmitter binds to two different receptor types that share the same ligand binding specificity (correct answer)
- The fast response is direct while the slow response requires protein synthesis of new signaling molecules
- The neurotransmitter undergoes metabolic conversion to a different molecule that activates the slow response
- The receptor changes conformation over time, first activating ion channels then activating enzymatic pathways
Explanation: When you encounter questions about neurotransmitters producing multiple distinct responses with different time courses, think about receptor diversity and signaling mechanisms. The key clue here is that both responses are blocked by the same competitive antagonist, which tells you something crucial about the binding sites involved.
The correct answer is B because competitive antagonists are highly specific - they block responses only when they compete for the exact same binding site as the natural ligand. Since one antagonist blocks both the fast electrical response and the slow metabolic response, both responses must originate from receptors that share identical ligand binding specificity. However, the dramatically different time courses (milliseconds vs. minutes) indicate these are functionally distinct receptor types - likely an ionotropic receptor for the fast response and a metabotropic receptor for the slow response.
Answer A is incorrect because a single receptor type cannot produce such vastly different temporal responses simultaneously. Answer C misses the mark because while protein synthesis might contribute to slow responses, it doesn't explain why one competitive antagonist blocks both responses - this requires shared binding specificity across different receptors. Answer D is wrong because if the neurotransmitter underwent metabolic conversion, a competitive antagonist blocking the original binding site wouldn't affect the converted molecule's actions.
Remember this pattern: when one competitive antagonist blocks multiple responses with different characteristics, look for multiple receptor subtypes with shared ligand specificity rather than single receptors or metabolic conversions. The specificity of competitive inhibition is your diagnostic tool.
Question 16
A researcher develops a biosensor that specifically detects protein-protein interactions between receptors and heterotrimeric G-proteins at the plasma membrane. When testing various signaling molecules, the sensor shows strong signals with serotonin and histamine application, weak transient signals with ATP, and no signal with insulin or estradiol. What can be concluded about these receptors?
- Serotonin and histamine receptors are G-protein coupled, ATP receptors are weakly coupled, while insulin and estradiol receptors are not membrane-associated
- All five molecules bind to different subtypes of G-protein coupled receptors with varying coupling efficiencies
- Serotonin and histamine bind to G-protein coupled receptors, ATP has mixed receptor types, while insulin and estradiol use non-G-protein mechanisms (correct answer)
- The sensor is detecting receptor clustering rather than G-protein interactions, which varies among receptor types
- All receptors couple to G-proteins but with different temporal patterns based on their downstream signaling requirements
Explanation: When you encounter biosensor questions in cell biology, focus on what the sensor actually detects and match those results to known receptor mechanisms. This biosensor specifically detects protein-protein interactions between receptors and heterotrimeric G-proteins at the plasma membrane.
The strong signals with serotonin and histamine indicate these molecules bind to classic G-protein coupled receptors (GPCRs), which undergo conformational changes that promote stable G-protein coupling. The weak, transient ATP signal suggests mixed receptor types - ATP can bind to both GPCRs (like P2Y receptors, giving weak signals) and ionotropic P2X receptors (which don't couple to G-proteins). The absence of signals with insulin and estradiol makes sense because insulin receptors are receptor tyrosine kinases and estradiol receptors are nuclear hormone receptors - neither mechanism involves heterotrimeric G-protein coupling.
Answer A is incorrect because it wrongly states that insulin and estradiol receptors aren't membrane-associated, when insulin receptors are actually membrane-bound receptor tyrosine kinases. Answer B incorrectly assumes all five molecules work through GPCRs with varying efficiencies, ignoring that insulin and estradiol use completely different signaling mechanisms. Answer D misinterprets the sensor's function - it's designed to detect specific G-protein interactions, not general receptor clustering.
Remember that different signaling molecules use distinct receptor mechanisms: GPCRs for many neurotransmitters and hormones, receptor tyrosine kinases for growth factors like insulin, and nuclear receptors for lipophilic hormones like estradiol. Match the biosensor's specificity to these known pathways.
Question 17
An inhibitor drug is designed to block the intrinsic kinase activity of certain receptors. In treated cells, growth factor-stimulated cell proliferation is completely blocked, but responses to adrenaline (increased cAMP) and acetylcholine (muscle contraction) remain normal. Which aspect of receptor function is this drug most likely targeting?
- The ligand-binding domains of G-protein coupled receptors
- The autophosphorylation capacity of receptor tyrosine kinases (correct answer)
- The ion channel gating mechanism of ligand-gated channels
- The DNA-binding ability of nuclear hormone receptors
- The G-protein coupling domains of metabotropic receptors
Explanation: When you encounter questions about drug inhibitors affecting specific cellular responses, focus on matching the inhibited pathway with the affected receptor type and its signaling mechanism.
The key clue here is that growth factor signaling is blocked while adrenaline and acetylcholine responses remain normal. Growth factors typically bind to receptor tyrosine kinases (RTKs), which have intrinsic kinase activity that becomes activated through autophosphorylation when the growth factor binds. This autophosphorylation is essential for RTK function and downstream signaling that promotes cell proliferation. A drug blocking "intrinsic kinase activity" would specifically target this autophosphorylation mechanism, explaining why growth factor responses are eliminated.
Choice B correctly identifies this autophosphorylation capacity as the drug target. The normal adrenaline and acetylcholine responses confirm the drug's specificity—these pathways don't rely on intrinsic kinase activity.
Choice A is incorrect because adrenaline works through G-protein coupled receptors, and if their ligand-binding domains were blocked, adrenaline responses would be impaired. Choice C is wrong because acetylcholine can work through ligand-gated ion channels for muscle contraction, and blocking these would eliminate the normal acetylcholine response observed. Choice D doesn't fit because nuclear hormone receptors don't have intrinsic kinase activity—they're transcription factors that bind DNA directly.
Remember: Match the drug's mechanism (kinase inhibition) with the receptor type that actually uses that mechanism (RTKs), and use the unaffected pathways to eliminate options that would block those specific receptor types.
Question 18
A cell biologist notices that when she adds a lipophilic signaling molecule to her cell culture, there's no immediate response, but after 45 minutes, specific mRNA levels increase dramatically. When she adds the same molecule to isolated cell membranes, no biochemical activity is detected. What type of receptor most likely mediates this response?
- A G-protein coupled receptor that slowly activates transcriptional responses through CREB phosphorylation
- A receptor tyrosine kinase that requires time to autophosphorylate and recruit transcription factors
- A nuclear hormone receptor that directly regulates gene transcription after ligand binding (correct answer)
- A ligand-gated ion channel that indirectly affects gene expression through calcium-dependent pathways
- An integrin receptor that activates MAP kinase cascades leading to transcriptional changes
Explanation: When you encounter questions about cellular signaling, pay attention to three key clues: the chemical nature of the signal molecule, the timing of the response, and where activity is (or isn't) detected.
The lipophilic (fat-soluble) nature of this signaling molecule is crucial—it can pass directly through cell membranes without needing surface receptors. The 45-minute delay before mRNA increases indicates transcriptional regulation, not the rapid responses typical of membrane-bound receptors. Most importantly, the lack of activity in isolated cell membranes tells you the receptor isn't located at the cell surface.
Answer C correctly identifies nuclear hormone receptors, which bind lipophilic molecules like steroid hormones, thyroid hormones, and retinoic acid. These receptors reside inside the cell (cytoplasm or nucleus) and directly bind DNA to regulate gene transcription, explaining both the delayed response and the dramatic mRNA increase.
Answer A describes GPCR signaling, but GPCRs are membrane-bound and would show activity in isolated membrane preparations. Answer B refers to receptor tyrosine kinases, which are also membrane receptors that would be active in membrane isolates and typically respond to hydrophilic proteins, not lipophilic molecules. Answer D involves ligand-gated ion channels, again membrane-bound receptors that would show activity in isolated membranes.
Remember this pattern: lipophilic signaling molecules + delayed transcriptional responses + no membrane activity = nuclear receptors. This combination appears frequently on cell biology exams because it tests your understanding of how molecular properties determine signaling mechanisms.
Question 19
A pharmaceutical company develops a drug that blocks all G-protein activity in cells. Which of the following cellular responses would still occur normally in the presence of this drug?
- Increased heart rate in response to adrenaline binding to β-adrenergic receptors
- Muscle contraction triggered by acetylcholine at the neuromuscular junction (correct answer)
- Activation of protein kinase A following glucagon binding to liver cells
- Smooth muscle relaxation in response to nitric oxide binding to guanylyl cyclase
- Increased intracellular calcium release following angiotensin II binding to vascular smooth muscle
Explanation: When you encounter questions about drug mechanisms affecting cellular signaling, focus on identifying which signaling pathways depend on G-proteins versus those that use alternative mechanisms.
G-protein coupled receptors (GPCRs) are crucial for many hormone and neurotransmitter responses. When a drug blocks all G-protein activity, it eliminates the ability of GPCRs to transmit signals from the cell surface to intracellular effectors like adenylyl cyclase or phospholipase C.
Option B is correct because acetylcholine at the neuromuscular junction works through nicotinic receptors, which are ligand-gated ion channels, not GPCRs. When acetylcholine binds, the channel opens directly, allowing sodium influx and muscle depolarization without requiring any G-protein intermediates.
Option A is wrong because β-adrenergic receptors are classic GPCRs. Adrenaline binding normally activates Gs proteins, which stimulate adenylyl cyclase to produce cAMP and increase heart rate. Blocking G-proteins would prevent this response.
Option C is incorrect because glucagon receptors are also GPCRs that work through Gs proteins. Glucagon normally activates adenylyl cyclase, producing cAMP that activates protein kinase A. Without functional G-proteins, this cascade cannot occur.
Option D is wrong because while nitric oxide does activate guanylyl cyclase directly, this pathway actually involves Gq-protein signaling upstream in most physiological contexts where NO is produced in response to receptor activation.
Study tip: Memorize the major receptor types - GPCRs require G-proteins, while ligand-gated ion channels and enzyme-linked receptors typically don't. This distinction appears frequently on cell biology exams.
Question 20
A pharmacologist studies two drugs that both bind to the same neurotransmitter binding site. Drug A causes immediate, brief membrane currents when applied. Drug B binds to the same site but causes no current; instead, it slowly increases intracellular cyclic AMP over several minutes. What explains this difference?
- Drug A activates the receptor while Drug B blocks it, preventing downstream signaling
- Both drugs activate the same receptor, but Drug A works faster due to higher binding affinity
- The neurotransmitter site is present on both a ligand-gated ion channel and a G-protein coupled receptor (correct answer)
- Drug A is an agonist for the receptor while Drug B is a partial agonist with different kinetics
- Drug A binds to the orthosteric site while Drug B binds to an allosteric modulatory site
Explanation: When you encounter a question about drugs producing different effects at the same binding site, think about receptor diversity. The key insight here is that the same neurotransmitter binding site can exist on completely different types of receptors with distinct signaling mechanisms.
The correct answer is C because many neurotransmitters bind to multiple receptor types. Drug A's immediate, brief currents indicate it's activating a ligand-gated ion channel, where binding directly opens an ion channel for rapid signaling. Drug B's slow cAMP increase over minutes is characteristic of G-protein coupled receptor (GPCR) activation, which triggers an intracellular cascade involving adenylyl cyclase. Both receptors recognize the same neurotransmitter binding site but transduce signals through entirely different molecular machinery.
Option A is wrong because Drug B clearly causes downstream signaling (cAMP increase), so it's not simply blocking the receptor. Option B incorrectly assumes both drugs work through the same receptor type—binding affinity differences wouldn't explain the fundamentally different response patterns (ion currents vs. cAMP). Option D misses the mark because partial agonism refers to reduced efficacy at the same receptor, not different signaling pathways entirely.
Remember this pattern: when you see the same ligand or binding site producing vastly different cellular responses (fast electrical vs. slow biochemical), consider receptor subtypes. Many neurotransmitters like acetylcholine, GABA, and glutamate have both ionotropic (ion channel) and metabotropic (GPCR) receptor families, allowing the same chemical signal to produce diverse physiological effects.